Assisted reproduction and preimplantation genetic diagnosis (PGD) involve various complicated techniques, each of them with its own problems. However, the greatest problem with PGD for chromosome abnormalities is not of a technical nature but is a biological phenomenon: chromosomal mosaicism in the cleavage stage embryo. Here, we present a hypothetical, quantitative model for the development of chromosomally normal, abnormal and mosaic embryos. The arising of mosaicism in 2±8-cell embryos was described by a binomial probability model on the occurrence of mitotic events inducing chromosomal changes in the blastomeres. This model converted the`mean' rate of mosaicism found in cross-sectional studies (60%) into an equal rate of mosaic embryos at arrival at the 8-cell stage (59.8%). The disappearance of >90% of the mosaic embryos or the mosaicism itself from surviving embryos during the morula stage was explained by mitotic arrest of most of the mitotically changed cells under increasing cell cycle control. In our model, 25.9 and 14.3% of the embryos at the 8-cell stage are normal and abnormal respectively. The remaining 59.8% of the embryo shows mosaicism: 34.6% of abnormal/normal cells and 25.2% of abnormal/abnormal cells. The high proportion of abnormal and mosaic embryos together explains the high rate of abnormal laboratory ®ndings in PGD for chromosomal abnormalities and aneuploidy screening. The poor representation of a 1-or 2-cell biopsy for the 7-or 6-cell post-biopsy embryo in the case of mosaicism explains the high rate of false-negative and false-positive results.
Introduction
The chance of a live birth following conception is estimated between 22 and 50% in the human (Roberts and Lowe, 1975; Edmonds et al., 1982; Chard, 1991; Norwitz et al., 2001; Macklon et al., 2002) . The majority of the conceptional losses occurs unnoticed through non-or failed implantation, and only a minority through spontaneous abortion of recognized pregnancies (Edmonds et al., 1982; Wilcox et al., 1988 Wilcox et al., , 1999 Norwitz et al., 2001) . A high rate of chromosomal abnormalities has been found in preimplantation embryos (Angell et al., 1986; Plachot et al., 1988; Papadopoulos et al., 1989; Jamieson et al., 1994; Munne Â et al., 1997; Bielanska et al., 2002; Clouston et al., 2002) and in embryonic/fetal or extraembryonic tissues after spontaneous abortion (Boue Â and Boue Â, 1976; Warburton et al., 1978; Hassold et al., 1980; Byrne et al., 1985; Fritz et al., 2001) . A markedly lower rate has been encountered in induced abortion specimens and in vital pregnancies at prenatal diagnosis (Kajii et al., 1978; Los et al., 2001) . This indicates that chromosomal abnormalities are the major cause of embryonic loss.
High frequencies of mosaicism up to 70% have been reported in preimplantation embryos (Munne Â et al., 1995 (Munne Â et al., , 1997 Voullaire et al., 2000; Wells and Delhanty, 2000; Bielanska, 2002) . However, the frequency of chromosomal mosaicism in spontaneous abortion specimens is <10% (Warburton et al., 1978; Hassold, 1982; Fritz et al., 2001) . In vital pregnancies, a low but regular frequency of mosaicism of~2% is encountered at prenatal diagnosis in chorionic villi: the smaller part (12%) represents true or generalized mosaicism and the greater part (88%) con®ned placental mosaicism (CPM) (mosaicism or homogeneous abnormality present in the extraembryonic tissues only, the fetus being normal) (Kalousek and Dill, 1983; Pittalis et al., 1994; Wolstenholme, 1996; Hahnemann and Vejerslev, 1997a,b) . Most mosaic embryos are lost apparently prior to the period of ®rst trimester spontaneous abortion.
For a good understanding of the loss of chromosomally normal, abnormal and mosaic embryos before, during and after implantation, a quantitative model might be helpful. Such knowledge could be essential in the interpretation of diagnostic results of preimplantation genetic diagnosis (PGD) of chromosomal abnormalities and PGD aneuploidy screening (PGD-AS). PGD-AS is carried out increasingly at present Munne Â et al., 1999; Kahraman et al., 2000; Vandervorst et al., 2000 ; ESHRE PGD Consortium Steering Committee, 2002; Voullaire et al., 2002) . Qualitative or (semi)quantitative models for cause and effects of chromosomal abnormalities during (early) pregnancy are scarce (Leridon, 1973; Plachot et al., 1987 Plachot et al., , 1988 Wolstenholme, 1995 Wolstenholme, , 1996 Clouston et al., 2002) . The`audit of trisomy 16 in man' (Wolstenholme, 1995) is an example of a detailed quantitative model con®ned to one speci®c chromosome (chromosome 16). Here, we would like to present a general quantitative model describing the fate of chromosomally normal, abnormal and mosaic embryos from fertilization to viable pregnancy at the end of the ®rst trimester of pregnancy comprising the total of numerical and structural chromosome abnormalities.
For this model, we used cytogenetic data from earlier studies as well as from the most recent literature on oocytes, sperm, embryos, spontaneous abortions and viable ®rst trimester pregnancies. The cytogenetic data on preimplantation embryos were derived over the years from many IVF programmes and concerned nontransferred embryos of selected patients. The embryos have been partially investigated (karyotyping a single blastomere or some of the blastomeres at most) or totally investigated with techniques allowing for the study of a restricted number of chromosomes [¯uorescence in-situ hybridization (FISH) of some chromosomes of all blastomeres]. In some instances, however, embryos were totally investigated with still experimental techniques but allowing for the study of all chromosomes including imbalanced structural abnormalities [whole genome ampli®cation (WGA) and single cell comparative genomic hybridization (CGH) of all blastomeres]. Various limitations and biases might be present in the translation of these in vitro data to the presumed in vivo situation.
For the description of the arising of mosaicism, we converted the`mean' ®gure of mosaicism in 2±8-cell embryos derived from cross-sectional studies into a`longitudinal' ®gure of mosaicism after the ®rst three mitotic cell divisions that are without full cell cycle control. This was done with binomial probability calculations: we assumed that a mitotic event changing the chromosomal condition of a cell could hit any blastomere at random with a certain probability. After the third post zygotic cell division at the 8-cell stage, the cumulative`longitudinal' ®gure of arisen mosaic embryos was assumed to be equal to the mean`cross-sectional' ®gure. For the description of the disappearance of mosaic embryos and of mosaicism itself from surviving embryos, we developed another concept that was also applicable to non-mosaic abnormal embryos. Chromosomal abnormalities of meiotic origin and mitotically induced chromosomal alterations can make the affected embryonic cells survive or non-survive cell cycle control, which becomes fully active during the morula stage. These concepts on the arising of mosaicism during the cleavage stage and on the disappearance of mosaic embryos and of mosaicism itself during the morula stage, enabled us to construct a model for the rise and fall of mosaicism during embryonic development up to the blastocyst stage. We extended this to a general, quantitative model for the development of chromosomally normal, abnormal and mosaic embryos throughout the ®rst trimester of pregnancy.
Background

General
In the model, the numbers of cytogenetically normal, abnormal and mosaic embryos are calculated and described at the level of zygote, 2-, 4-and 8-cell cleavage stage embryo, 16-and 32-cell morula, free blastocyst, hatched blastocyst, embryo, and early fetus. Additionally, the change of these numbers by events or conditions separating the various levels of development such as fertilization, mitotic arrest, occurrence of mitotic chromosome errors, occult abortion, ®rst trimester spontaneous abortion, etc., are presented.
The various phases of the cell cycle are regulated by a complicated system: the cell cycle control system (for review, see Alberts et al., 2002a,b) . In the early embryo, cell cycle control is performed by maternal transcripts present in the ooplasm (Braude et al., 1988; Lighten et al., 1997; Alberts et al., 2002a,b) . However, some of the checkpoints of the cell cycle control system are lacking in the ®rst postzygotic cell divisions (Alberts et al., 2002a,b) . Only after the expression of the embryonic genome, cell cycle control becomes gradually present from the 8-cell stage onwards during the morula stage (Tesar Ïik et al., 1986; Braude et al., 1988; Lighten et al., 1997) . Also the mechanism of programmed cell death (apoptosis) becomes active during the morula stage (Jurisicova et al., 1996 (Jurisicova et al., , 2003 Hardy et al., 2001) . The fact that maternal transcripts are responsible for the cell cycle control in the ®rst embryonic cell divisions implies theoretically that the effects of control are`maximal' in the ®rst division and decrease in each following division. For our model, we assumed a limitation of cell cycle control in the ®rst three postzygotic cell divisions to such an extent, that mitosis was not blocked for the majority of cells: 17.5% of the embryos were affected by mitotic arrest (see Numbers). Furthermore, we assumed an increasing cell cycle control during the morula stage (8±64-cell stage) and a fully active one from the free blastocyst stage (b 64-cell stage) onwards.
The separation of omnipotent blastomeres into the compartments of trophoblast and inner cell mass (ICM) takes place between the 8-and 16-cell stage (Crane and Cheung, 1988; Bianchi et al., 1993) . In case of chromosomal mosaicism at the 8-cell stage, there has been found no indication for a non-random allocation of chromosomally abnormal cells to the trophoblast compartment (Mottla et al., 1995; Evsikov and Verlinsky, 1998; Magli et al., 2000) . However, the blastomeres showing the fastest development are preferentially allocated to the ICM in the preimplantation mouse embryo (Spindle, 1982) . Tetraploid cells are predominantly distributed to the compartments of trophoblast and extra-embryonic mesoderm (EEM), but not to that of the embryo/fetus proper (James and West, 1994; James et al., 1995) . At the free blastocyst stage (probably between the 64-and 128-cell stage), the ICM separates into the compartments of the epiblast (the future embryo/fetus proper) and the hypoblast (the future EEM) (Hinrichsen, 1990) . It is not known if there is a non-random allocation of normal cells present in the ICM to the compartment of the embryo/fetus proper. For tetraploid cells, a preferential allocation to the compartment of the EEM rather than to that of the embryo/fetus proper in the mouse has been found (James et al., 1995) . As far as of importance for our model, we assumed random distributions.
Numbers
The starting point of the model was the number of 100 000 zygotes. We assumed that 100 000 zygotes would ®nally result in 25 000 viable fetuses (25%) at the beginning of the second trimester of pregnancy, close to the estimate (22%) of Roberts and Lowe (1975) . In the in vitro situation, 40±50% of the zygotes develop into a free blastocyst (Almeida and Bolton, 1996; Jones et al., 1998; Rijnders and Jansen, 1998; Alikani et al., 2000; Zollner et al., 2002) . We considered this range indicative for the presumed in vivo situation in our model: this assumption might imply a source of bias.
The rate of pregnancy loss after recognized implantation (detected with sensitive assays for hCG in women's urine) is 31% (Wilcox et al., 1988; Zinaman et al., 1996) . The loss rate of clinically recognized pregnancies through spontaneous abortion is positively correlated with maternal age; the average ®gure of 15% for the pregnant population was assumed in our model (Hassold and Chiu, 1985; Fonteyn and Isada, 1988) .
Mitotic arrest of the ®rst cell division was assumed to occur in 12.5% of zygotes (Wimmers and Van der Merwe, 1988; Benkhalifa et al., 1996; Wittemer et al., 2000) . Mitotic arrest in both the second and third cell division was assumed to affect an arbitrary number of 2500 embryos (~3%) since cell cycle control might be less prevalent in these divisions than in the ®rst cell division (see General).
Cytogenetics
The cytogenetic condition of embryos at the various levels of development from gamete until the end of the ®rst trimester of pregnancy is presented in Table I . Insuf®cient data or no data at all were available at the various cell stages of the morula, free, hatched and implanting blastocyst, at the levels of recognized implantation and clinically recognized pregnancy and, ®nally, of the event of occult abortion.
The cytogenetic data from oocytes were derived from unfertilized oocytes of women in IVF programmes, a selected population of oocytes of a selected population of women that might not be representative for the oocytes of the general population of pregnant women in the in vivo situation. Plachot et al. (1988) and Pellestor et al. (2002) , however, did not ®nd signi®cant differences between the various types of female or male infertility and the frequency of aneuploidy in oocytes. Also, the process of fertilization seems not to be in¯uenced by the level of chromosome abnormalities of the oocyte (Plachot et al., 1988; Almeida and Bolton, 1994; Pellestor et al., 2002) . Maternal age selection could introduce a wrong estimate of cytogenetically abnormal oocytes, since the frequency of chromosome abnormalities increases in preimplantation embryos and spontaneous abortion specimens with advancing maternal age due to increased meiotic non-disjunction (Hassold et al., 1984; Hassold and Chiu, 1985; Bielanska et al., 2002; Munne Â et al., 2002) . Some authors actually found the expected, increased rate of aneuploidy in oocytes of women of advanced maternal age (Plachot et al., 1988; Angell et al., 1997) , but others did not ®nd this so clearly (Pellestor, 1991; Pellestor et al., 2002) . In the studies on chromosome abnormalities in oocytes of Table I , the maternal ages were, if skewed, skewed towards an advanced rather than to a younger maternal age. For instance, Pellestor et al. (2002) studied the oocytes from women aged 33.7 T 4.7 (mean T SD) years with a range from 19 to 46 years. We believed that our assumed abnormality rate of 26% in oocytes might be fairly representative for the general female population. The cytogenetic data of sperm were derived from normal men and were considered to re¯ect the general male population.
Cleavage stage embryos (arrested and developing embryos) have initially been studied using karyotyping of cultured blastomeres. Although allowing for complete investigation of all chromosomes comprising numerical as well as structural abnormalities, the yield of harvested and analysable metaphases has always been low. This is the reason why karyotyping is not suitable for the investigation of mosaicism in embryos. Therefore, the FISH technique allowing for the investigation of blastomeres at the interphase level has been widely applied, notwithstanding the serious limitation that numerical abnormalities of a restricted number of chromosomes can be investigated (up to nine chromosomes in the studies of Table I ). Structural chromosome rearrangements can only be investigated to some extent, in case of parental carriership (Scriven et al., 1998) . However, FISH is very suitable for the investigation of mosaicism of the chromosomes of concern (Munne Â et al., 1994 (Munne Â et al., , 1995 Bielanska et al., 2002) . Extrapolation of FISH data on mosaicism of certain chromosomes to the presumed frequency of mosaicism of all chromosomes has been proposed by the use of certain multiplication factors, but generally resulted in overestimation of this frequency (Wells and Delhanty, 2000) . The complicated and still experimental technique of WGA and subsequent single cell CGH combines most of the possibilities of karyotyping and the advantages of FISH (Wells and Delhanty, 2000; Voullaire et al., 2000 Voullaire et al., , 2002 . Although experimental and carried out on a small sample of selected embryos, the WGA + CGH analyses on 3±8-cell embryos conducted by Wells and Delhanty (2000) and Voullaire et al. (2000) showed comparable and similar results to an extent that could not be explained by coincidence. Their values for the frequency of mosaicism in preimplantation embryos of 67% must be a fairly good estimate of the frequency of chromosomal mosaicism in the population of human embryos. Mosaicism comprised mosaicism of abnormal/normal cells (A/N) as well as of abnormal/abnormal cells (A/A). We believed that our assumption of a`cross-sectional' frequency of chromosomal mosaicism (A/N and A/A) of 60% in 2±8-cell embryos based on the`extrapolation' of the FISH data of Table I in combination with the reported WGA + CGH data was justi®ed.
We used the proportions of single monosomies and trisomies among the homogeneous abnormalities in embryos of 0.30 and 0.233 respectively, as established by karyotyping of zygotes (Almeida and Bolton, 1996) . The slightly higher rate of monosomy than of trisomy has also been encountered with the FISH and WGA + CGH techniques Voullaire et al., 2002) .
The values for non-mosaic and mosaic chromosome abnormalities in tissues after spontaneous abortion and induced abortion of a vital pregnancy as well as those found at prenatal diagnosis in chorionic villi are well established and need no further discussion.
We assumed, according to the observations of Sandalinas et al. (2001) , that cells with haploidy, polyploidy (b5n), monosomy (other than monosomy X or 21), multiple trisomy (in most but not all instances), extensive aneuploidy (chaotic chromosomal constitution) and severe structural chromosome rearrangements would not survive cell cycle control beyond the 8-cell stage: lethal cells. Cells with single and some with multiple trisomy, monosomy 21, sex chromosomal aneuploidy, less severe structural chromosome rearrangements, tetraploidy and triploidy were assumed to survive Munne Â et al., 1995 (X, Y, 15, 16, 17, 18) 16 56 Iwarsson et al., 1999 (1, 4, 6, 7, 14, 15, 17, 18, 22) 38 31 Bahc Ëe et al., 1999 (X, Y, 13, 14, 15, 16, 18, 21, 22) 32 30 Gianarolli et al., 1999 (X, Y, 18/2, 7, 18/13, 16, 18, 21, 22) Munne Â et al., 1995 (1, 4, 6, 7, 14, 15, 17, 18, 22) 56 32 Bahc Ëe et al., 1999 (X, Y, 18/2, 7, 18/13, 16, 18, 21, 22) 35 Bielanska et al., 2002 (70) cell cycle control and keep their ability of cell division: viable cells. Mosaicism in embryos at the 8-cell stage with 1 cell or 2 cells that had become abnormal by (a) mitotic event(s) next to 7 or 6 original (normal or abnormal) cells was designated limited mosaicism (Sandalinas et al., 2001) . Mosaicism of b3 (daughter cells of) mitotically changed cells next to`5 original (normal or abnormal) cells was designated substantial mosaicism.
Mechanisms
Chromosomal abnormalities are of meiotic or mitotic origin or both: a mitotic event might affect a normal as well as an abnormal cell. A mitotic event might even hit a daughter cell of a previously hit blastomere inducing a second change in the karyotype. We considered three mechanisms for the induction of mitotic chromosome errors: non-disjunction (ND), anaphase lagging (AL) and`structural events' (SE) of DNA damage or chromatid/ chromosomal breakage causing structural chromosome rearrangements (translocations, deletions, duplications, marker or ring chromosomes, etc.). Other possible mechanisms of chromosome loss or damage, such as fragmentation or pulverization, were not separately considered: we assumed that their effects of chromosome loss and/or induction of structural chromosome rearrangements were comprised in the mechanisms of AL and SE. Blastomeres with complex chromosome abnormalities, also known as chaotic cells and characteristic for preimplantation embryos (Harper and Delhanty, 1996) , were thought to have arisen by ND (or sometimes by AL) involving multiple chromosomes simultaneously: their effects were assumed to be comprised in the mechanisms of ND (or AL). Finally, we considered only divisions leading to two daughter cells for our model and discarded divisions giving rise to three daughter cells, which might occur in cases of three pronuclei (Kola et al., 1987) .
ND results in two differently abnormal daughter cells, one cell with loss of a chromosome and the other cell with the reciprocal gain of that chromosome. When ND concerns two or multiple chromosomes simultaneously, a random mixture of reciprocal gains and losses of the various chromosomes in the daughter cells can be expected. Special situations occur when cells displaying single trisomy or monosomy are affected by ND involving only that speci®c chromosome which then corrects one daughter cell to normal disomy and makes the other tetrasomic or nullisomic. These situations are known as trisomic zygote rescue (TZR) and monosomic zygote rescue (MZR) respectively, and are characterized by uniparental disomy (UPD) in a proportion of the corrected cases (Spence et al., 1988; Kalousek and Barret, 1994; Ledbetter and Engel, 1995; Wolstenholme, 1995 Wolstenholme, , 1996 .
AL involves both chromatids of a chromosome in 36% of cases and one chromatid in 64% of cases giving two identically abnormal daughter cells or one abnormal and one unchanged daughter cell respectively (Ford et al., 1988) . In the case that AL concerns two or multiple chromosomes and/or chromatids simultaneously, a random mixture of losses of the different chromosomes among the daughter cells can be expected, resulting in a few unchanged daughter cells. Also the special situation of TZR can occur, when AL corrects a cell with single trisomy to two normal daughter cells or one normal and one original daughter cell.
Structural chromosome rearrangements by SE might involve one chromatid or both chromatids of a single chromosome and more chromosomes simultaneously (for instance in reciprocal translocations). We assumed a 0.5:0.5 ratio for the situations of one abnormal and one unchanged daughter cell versus two identically abnormal daughter cells. Potential malsegregation of the arisen derivative chromosome(s) among the daughter cells was thought to be part of the SE mechanism.
The already mentioned very detailed studies by Wells and Delhanty (2000) and Voullaire et al. (2000) comprising numerical as well as unbalanced structural chromosomal abnormalities tempted us to make an estimate of the relative frequencies of these three mechanisms of mitotic events. In this estimate, the minimum number of mitotic events needed to explain (or explain') the various, mitotically changed karyotypes in all the analysed blastomeres was considered. Only zero or one mechanism per cell per division could be attributed. Sometimes, simultaneous events in different cells during the same cell division or consecutive events in subsequent cell divisions of already mitotically changed cells had to be considered. We performed this estimate according to the example given by the authors (Voullaire et al., 2000) . In our hands, the ratio of ND:AL:SE turned out to bẽ 5:5:2. There was a risk of underestimating the frequency of AL and overestimating that of ND, because it was not always clear whether a monosomy present in some cells of an embryo originated from a normal embryo hit once by AL or represented a case of MZR by ND. Furthermore, these two studies tempted us to speculate on the ratio of single chromosome/chromatid versus multiple chromosomes/chromatids involvement in mitotic events: we established a ratio of 6:4. There were considerable differences between the mechanisms on this point. SE involved a single chromosome in all 5 events, AL in 10/11 events (91%) and ND in 3/14 events (21%). Because of the small involvement of multiple chromosomes simultaneously in AL, we did not modify the abovementioned fractions of changed and unchanged daughter cells after a mitotic event by AL concerning a single chromosome/chromatid in the probability calculations for the model. In a normal cell, ND concerning a single chromosome (21% of the events) gives rise to 1 trisomic and 1 monosomic cell, the ®rst being viable and the second lethal. ND concerning more chromosomes simultaneously (79% of the events) will result in only a few viable cells (arbitrarily set at 5%) and a vast majority of lethal cells (95% Abnormal cells affected by ND, AL and SE will show more seriously abnormal karyotypes than normal cells. Therefore, we assumed a 50% decrease in the fraction of viable cells for ND and SE resulting in lethality rates of 0.927 for ND and 0.75 for SE. We did not expect an abnormal cell to survive a hit by AL delivering a lethality rate of 1.00. The mean lethality rate of mitotically changed cells from abnormal origin is 92.5%. Mitotically changed cells that were hit by a second or even a third mitotic event in a subsequent cell division were supposed to be lethal in all instances.
In the two WGA + CGH studies of Wells and Delhanty (2000) and Voullaire et al. (2000) , we estimated the proportions of lethal and viable cells among the mitotically changed cells according to the de®nitions given in Cytogenetics above at 78 and 22% respectively. Although the range of our theoretically calculated lethality rate from 83.0 to 92.5% was not quite in agreement with the`actual' estimated rate of 78%, we believed that our assumptions on the mechanisms of ND, AL and SE were well applicable to our model.
Calculations
For our hypothetical model, we assumed that a mitotic event could hit any blastomere of a 1-, 2-or 4-cell embryo at random with a certain probability (p) during mitosis. The probability that a blastomere would not be hit was q (= 1 ± p). Such a situation could be described by binomial probabilities (Zarr, 1999) . We considered only the mitotic events that occurred in the ®rst three mitotic cell divisions without full cell cycle control, allowing for further cell division(s) of the majority of the karyotypically changed cells. The formulae for binomial probability calculations in these cell divisions are shown in Table II . Since we were for this part of the calculations only interested in the number of embryos of which b1 cells were hit by b1 mitotic events and not in that of the unaffected embryos, this could be described by the formula (p + q) n ± q n = (1) n ± (1 ± p) n = 1 ± (1 ± p) n delivering the formulae for the ®rst, second and third cell division:
1-cell stage (n = 1): p 2-cell stage (n = 2): 1 ± (1 ± p) 2 4-cell stage (n = 4): 1 ± (1 ± p) 4 . Multiplication of probabilities by the numbers of embryos (= N) would then deliver the numbers of embryos affected by (a) mitotic event(s) at the various cell stages.
However, a mitotic event in the ®rst division might lead to mosaicism in case of 2 differently changed daughter cells (A/A) or 1 changed and 1 original daughter cell (A/N or A/A), to homogeneous abnormality in case of 2 identically changed daughter cells and even to normality in case of TZR or MZR. The chance of 2 different daughter cells after a mitotic event was calculated at 0.767 (see Mechanisms above). So, the probability that a mitotic event in the ®rst mitotic division would result in mosaicism was 0.767p. In the second and third division, (a) mitotic event(s) always would lead to mosaicsm; no further corrections were needed concerning this point. Mitotic events in the second and/or third mitotic cell division of an embryo with mosaicism already formed in (a) previous division(s), would not lead to a new case of mosaicism but only to an aggravation of the existing mosaicism. In the calculation of the number of mosaic cases among the embryos undergoing mitotic events, N had to be corrected by the subtraction of the number of already existing cases of mosaicism. In the same way, a correction should be made for the embryos lost by mitotic arrest. This last correction was omitted because it would only lead to minor changes in values but major problems in calculations. The value of 60% for mosaicism at the 2±8-cell stage (see Cytogenetics section), N as the mean of the N values at the 1-, 2-and 4-cell stages, the above-mentioned formulae and corrections enabled us to describe the relation between the`cross-sectional' value of 0.60 and p for our longitudinal model in the following equation:
From the 8-cell stage onwards, the decay curves of the total number of embryos as well as that of normal, homogeneously abnormal and mosaic embryos separately were assumed to be optically comprehensive curves. Therefore, estimations and calculations (multiplication, addition and subtraction) were conducted from the top (8-cell stage) downstream as well as from the bottom (early fetus) upstream. This method was chosen because of the lack of data on the cytogenetic condition of embryos between the 8-cell stage and the level of recognized pregnancy (see Cytogenetics section).
As mentioned in the Mechanisms section, a cell division of an abnormal blastomere might accidentally deliver 2 normal daughter cells or a mosaicism of 1 normal and 1 abnormal cell in case of TZR or MZR. For monosomy corrected to nullisomy/disomy by ND (MZR) assuming equal frequencies of all different monosomies, this value was given by the following product: chance of (a) mitotic event(s) in the cell division of concern Qchance of a ND correction involving a single chromosome (0.21 Q 5/12 = 0.0875) Q chance that the single chromosome involved was a speci®c chromosome (22/23 Q 1/45 (autosomes) + 1/2Q1/23Q1/45 (45,X) = 0.02174 Q fraction of single monosomy among the homogeneous abnormalities (0.30) Q number of homogeneous abnormalities at the cell stage of concern.
In the same way and under the assumption of equal frequencies of all different trisomies, the calculation could be made for trisomy corrected to trisomy/disomy or disomy by AL and tetrasomy/ disomy by ND (TZR): chance of (a) mitotic event(s) in the cell division of concern Q chance that a Q number of homogeneous abnormalities at the cell stage of concern.
All the discussed parameters and calculation methods needed for the construction of the model are summarized below:
General: cell cycle control; de®nition of embryonic compartments.
Numbers: de®nition of starting point (100 000 zygotes); ®nal number of viable fetuses at the beginning of the second trimester of pregnancy (25 000); rate of zygotes developing into free blastocysts (40±50%); rate of pregnancy loss after recognized implantation (31%); numbers of embryos lost by mitotic arrest in ®rst (12 500), second (2500), and third (2500) Mechanisms: mechanisms and effects of the mitotic events (AL, ND and SE); relative frequencies of AL:ND:SE = 5:5:2; ratios of 1 changed and 1 original (0.35), 2 differently changed (0.417) and 2 identically changed (0.233) daughter cells after mitotic events; lethality rates of daughter cells of normal cell hit by ND (0.855), AL (0.934) and SE (0.50); lethality rates of daughter cells of abnormal cell hit by ND (0.927), AL (1.00) and SE (0.75); mechanisms and effects of TZR and MZR.
Calculations: binomial probability calculations; equation for the conversion of a cross-sectional into a longitudinal model; calculations for TZR and MZR.
Model for development of embryos
The model, which describes quantitatively the development of chromosomally normal, abnormal and mosaic embryos, is presented in Table III and Figure 1 . More details on the disappearance of mosaic embryos and of mosaicism from surviving embryos are shown in Table IV and on the levels of mosaicism at the 8-cell stage in Figure 2 . We will now explain the construction of the model in detail.
With the abnormality rates in sperm (10%) and oocytes (26%) and the rate of induction of abnormalities by the process of fertilization (8%), the numbers of 61 000 normal and 39 000 abnormal zygotes could be calculated. Since 70% of the arrested zygotes and 2±8-cell embryos showed cytogenetic abnormalities, 70% of the values for mitotic arrest were attributed proportionally to abnormal and mosaic embryos. The total numbers of embryos (N) at the 1-, 2-and 4-cell stage of development after subtraction of the values of mitotic arrest were 87 500, 85 000 and 82 500 respectively Table III . Subtraction and addition then delivered the numbers of normal, abnormal and mosaic embryos reaching the 2-cell stage. Multiplication of these numbers of embryos (after subtraction of the numbers of mitotic arrest) by 0.238 delivered the numbers of new mosaic cases arisen from normal and abnormal embryos as well as the number of aggravated mosaic cases arisen from mosaic embryos. The same implementation of the ratios for changed daughter cells and the calculations for TZR and MZR completed the values for the second cell division. Subtraction and addition resulted in the numbers of normal, abnormal and mosaic embryos arriving at the 4-cell stage. The calculations at the 4-cell stage were performed in exactly the same way as at the 2-cell stage, giving the various numbers for the third cell division. The difference between the theoretical and actually calculated numbers and fractions of mosaic embryos at the 8-cell stage (51 000/85 000: 60.0% and 49 352/82 500: 59.8%) was due to the omission of the correction for embryos lost by mitotic arrest in the equation (see Calculations section).
With the substitution of p = 0.127 and q = 0.873 in the terms of the binomial (p + q) 2 of Table II, the numbers of normal, abnormal and mosaic embryos undergoing 2, 1 and 0 (simultaneous) mitotic events in the second cell division could be calculated out of the numbers of surviving embryos that had undergone 1 and 0 mitotic events in the ®rst cell division. The implementation of the relative ratios of 1 and 2 (identically or differently) changed daughter cells and the nature of the cell(s) (normal, abnormal or already mitotically changed) hit by (a) mitotic event(s) further enabled us to establish the levels of mosaicism within these numbers of embryos. In the same way, the numbers of normal, abnormal and mosaic embryos undergoing 4, 3, 2, 1 and 0 (simultaneous) mitotic events in the third cell division could be calculated with the probabilities of the terms of the binomial (p + q) 4 and the numbers of surviving embryos after 2, 1 and 0 events in the second cell division. The relative ratios of changed daughter cells and the nature of hit cells were implemented as in the second cell division. These subsequent calculations resulted in the numbers of normal, abnormal and mosaic embryos that had undergone all possible combinations of 0, 1 or b2 (simultaneous and/or consecutive) mitotic events in 1, 2 or all 3 of the ®rst 3 mitotic cell divisions. The numbers of mosaic embryos at each level of mosaicism (A/N and A/A) at the 8-cell stage are presented in Figure 2 . The values of mosaic embryos with even numbers of changed cells are higher than with odd numbers. This can be explained by the fact that a cell division of odd as well as even numbers of cells always leads to an even number of daughter cells. Mitotically changed lethal cells show mitotic arrest under cell cycle control from the 8-cell stage onwards. Limited mosaicism of 1 or 2 lethal cells would then show the disappearance of these cells, leaving only the original cells: a shift from mosaicism towards normality (in case of A/N mosaicism) or homogeneous abnormality (in case of A/A mosaicism) occurs during the morula stage. We were aware of the fact that the dichotomous variable of viability or lethality of the original cell line created a real and a virtual component of this shift. It concerned those embryos hit once or twice in the third cell division by a mitotic event delivering 1 or 2 lethally changed cells (A [1] /N [7] During the morula stage, a substantial proportion (37 500/82 500 = 45.5%) of embryos is lost by arrested development (Table IV) . The contributions of the normal, abnormal and mosaic embryos to the combined values of embryo loss and shift from mosaicism towards normality or homogeneous abnormality were established using the values from the optically best-®tting decay curves. Therefore, the virtual situation of localizing this complete shift at the 8-cell stage was introduced: the virtual 8-cell stage (Table IV) . From this virtual 8-cell stage onwards, we searched for the best ®t of the downstream and upstream values. Subtraction and addition delivered the numbers of normal, abnormal and mosaic embryos lost by non-implantation and those at the levels of recognized implantation and recognized pregnancy (Tables III, IV and Figure 1) .
From the virtual 8-cell stage, only 1.7% of the mosaic embryos (500/28 961) and 3.8% of the homogeneously abnormal embryos (750/19 562) but as much as 69.9% of the normal embryos (23 750/ 33 977) reached the stage of viable pregnancy (Tables III and IV) . At the actual 8-cell stage, the lowest level of chromosomally normal embryos (25.9%) is associated with the highest level of abnormal and mosaic embryos (74.1%) (Tables III and IV, Figure 1 ).
As can be seen in Table III , eight normal and 133 mosaic cases (A/N) have arisen in the ®rst three cell divisions due to accidental TZR or MZR. The majority of the mosaic cases was derived from trisomic conceptions (n = 122) and a minority from monosomic conceptions (n = 11). The eight normal cases were all derived from trisomic conceptions.
Discussion
The rates of homogeneous abnormalities (8%) and mosaicism (67%) in cleavage stage embryos as found by Voullaire et al. (2000) and Wells and Delhanty (2000) with WGA + CGH studies give a total cytogenetic abnormality rate of 75%. This ®gure is remarkably similar to the conceptional loss rate of 78% estimated by Roberts and Lowe (1975) . Our theoretical model combines the development of 25 000 viable pregnancies out of 100 000 zygotes with rates of 14.3% for homogeneous abnormalities and 59.8% for mosaicism in embryos arrived at the 8-cell stage. This was achieved by the conversion of the`mean' value for mosaicism from cross-sectional studies in 2±8-cell embryos (60%) into a longitudinal, developmental model on the arising of mosaicism in the ®rst three mitotic cell divisions using binomial probability calculations. The disappearance of mosaic embryos and mosaicism from surviving embryos during the morula stage involved the implementation of the concept of lethality or viability of cells under cell cycle control. Cells with cytogenetic abnormalities of meiotic origin and/or induced by fertilization and/or mitotic events during the ®rst three mitotic cell divisions could survive or nonsurvive cell cycle control from the fourth cell division onwards. The cytogenetic conditions for this presumed surviving or nonsurviving of cells were given in the Cytogenetics section and the cells were accordingly designated viable or lethal.
Our assumed low values for arrested development of the preimplantation embryo in the early postzygotic cell divisions with limited cell cycle control are consistent with a mathematical model on developmental arrest of embryos in relation to cell death (Hardy et al., 2001) . According to this model, substantial cell death occurs not before the 8-cell stage:~50% of the embryos succumb during the morula stage and the remaining 50% reach the blastocyst stage. Also in our developmental model, the morula stage turned out to be the predominant graveyard for embryos, especially mosaic embryos. Not only in theoretical models but also in reality, it has been established that the majority of mosaic cleavage stage embryos does not reach the blastocyst stage (Evsikov and Verlinsky, 1998; Sandalinas et al., 2001; Bielanska et al., 2002) .
Uncontrolled passing on of numerical and structural chromosome abnormalities to daughter cells in the ®rst cell divisions without full cell cycle control are the cause of mosaicism in the preimplantation embryo (Delhanty and Handyside, 1995; Conn et al., 1998; Bielanska et al., 2002) . The activation of the embryonic cell cycle control system from the 8-cell stage onwards causes developmental arrest of many mosaic embryos and eliminates previously formed mosaics during the morula stage. The arising of further mosaics other than sporadic cases is prevented since 83.0±92.5% of mitotically changed cells show mitotic arrest. So, the number of mosaics is at its highest at the 8-cell stage of embryonic development. An association of increasing frequencies of mosaicism and increasing numbers of blastomeres in cleavage stage embryos has been observed with FISH studies (Bielanska et al., 2002) .
Mosaic embryos with limited mosaicism of lethal cells (A [1, 2] / N [7, 6] or A [1, 2] /A [7, 6] ) have been proposed to continue further cell divisions or to succumb as normal or homogeneously abnormal embryos dependent on the lethality or viability of the original cells. This phenomenon was called the shift of mosaicism towards normality or homogeneous abnormality: this shift comprised a real component (in case of embryo survival) and a virtual one (in case of developmental arrest). Mosaic embryos with substantial mosaicism of lethal cells (A [b3] /N [`5] or A [b3] /A [`5] ) are nonviable irrespective of the lethality or viability of the original cells and fail to reach the blastocyst stage (Sandalinas et al., 2001; Voullaire et al., 2002) . Mosaic embryos with limited or substantial mosaicism of viable cells whilst the original cells are lethal succumb during the morula stage. Mosaic embryos with limited or substantial mosaicism of viable cells and viable original cells (normal or abnormal) might continue further cell divisions but might, dependent on the severity of the chromosomal abnormalities, show differences in growth velocities between the various cell lines. Major differences might lead to irregularities in the shape of the blastocyst or its ICM and hence in hampered or nonimplantation (Richter et al., 2001) . After initially successful implantation, minor differences in growth velocities might lead to disturbances in embryo and further trophoblast development with subsequent occult pregnancy loss. However, some cases of mosaicism might be without lethal consequences for embryonic and placental development and discovered later as generalized mosaicism or CPM at prenatal diagnosis. Embryos with multiple mosaicism (b3 different cells/cell lines) form the majority of mosaic embryos (almost 62%) in our model. Such embryos display limited or substantial mosaicism of different lethal, different viable or a mixture of (different) viable and (different) lethal cells/ cell lines [next to the original (viable or lethal) cell or cell line]. Dependent on the fractions of the lethal and viable cells/cell lines and their relative growth velocities, these embryos might theor-etically have each of the described developmental prospects. However, generalized mosaicism and/or CPM of b3 independent cell lines are very rare: virtually all embryos displaying multiple mosaicism are lost.
The above-hypothesized events explain the great decrease in numbers as well as in fractions of mosaic cases in the cell divisions during the morula stage. Such a decrease beyond the 8-cell stage has actually been observed in a study of chromosomal mosaicism in embryos throughout preimplantation development (Bielanska et al., 2002) . The increasing and decreasing frequency of mosaicism prior to and beyond the 8-cell stage respectively, as found by Bielanska et al. (2002) deliver the geometric shape of a parabola with the top at the 8-cell stage and is consistent with our model as shown in Figure 1 . Furthermore, the above-hypothesized events explain the non-or failed implantation of the majority of the mosaic embryos that have reached the free or hatched blastocyst stage.
Apart from the massive loss of mosaic embryos between the virtual 8-cell stage and the free blastocyst stage, a substantial number of homogeneously abnormal and a small number of normal embryos are lost. Homogeneously abnormal embryos consisting of lethal cells show mitotic arrest under cell cycle control during the morula stage, whereas those consisting of viable cells might continue further cell divisions. Apart from viability or lethality of cytogenetically abnormal cells under cell cycle control, other factors might cause mitotic arrest of cells during the morula stage. Recently, the role of epigenetic reprogramming of the preimplantation embryo has been reviewed as a possible cause of developmental disturbances (De Rijcke et al., 2002) . At the blastocyst stage, disturbances in the uterine blastocyst signalling may lead to non-implantation or failed implantation (Macklon et al., 2002; Paria et al., 2002) .
After successful implantation, disturbances in the development of the embryo proper due to homogeneous chromosomal abnormalities or viable mosaicisms in some cases may lead to blighted ovum, missed or spontaneous abortion (Boue Â and Boue Â, 1976; Byrne et al., 1985) . Finally, factors not related to chromosomal abnormalities can cause arrest of embryo development with subsequent abortion.
In our model, randomness of all events and hence of the occurrence of TZR and MZR has been assumed. Eight embryos with a normal karyotype and 133 cases of mosaicism did arise by TZR and MZR (see Table III ). Accidental correction of 1 cell with single trisomy or monosomy to 1 or 2 normal daughter cells occurred in these cases in the ®rst, second or third mitotic cell division. Assuming the same chances of survival for the eight normal cases as for originally normal embryos at the 2-cell stage (49 987 ± 8 = 49 979), a mean of four cases could be expected among the 23 750 normal fetuses at the end of the ®rst trimester of pregnancy. Two such rare cases have been discovered with DNA and (molecular) cytogenetic investigations (Los et al., 1998a) . The mosaic embryos with trisomy/disomy mosaicism might have better chances of survival than the whole group of mosaic embryos since they represent a selected population affected by an accidentally selected mitotic event, as we will see below.
A number of CPM cases involving single trisomy shows UPD (Robinson et al., 1997; EUCROMIC, 1999; Kotzot, 2002; Yong et al., 2002) . No CPM cases of monosomy/disomy mosaicism with UPD of the disomic cell line have been reported (Kotzot, 2002) . Van Opstal et al. (1998) established prospectively the frequency of UPD among cases of CPM III and/or I (investigation of the trophoblast compartment of chorionic villi only) involving single trisomy at 1/23 (4.3%) in a population of women that underwent prenatal diagnosis. Since the proportion of CPM III and/or I among the three types of CPM is 71% (Pittalis et al., 1994; Van den Berg et al., 2000) , we assumed a corrected incidence of UPD among all CPM types involving single trisomy of 3.1%. The 33.3% risk for UPD following TZR means that a theoretical proportion of 9.3% of the CPM cases involving single trisomy has been subjected to TZR. About 88% of the mosaic cases encountered in chorionic villi concern CPM and the other 12% generalized mosaicism; 40% of the CPM cases concern single trisomy (Pittalis et al., 1994; Leschot et al., 1996; Phillips et al., 1996; Los et al., 1998b; Van den Berg et al., 2000) . So, 16.4 of the 500 (0.093Q0.88Q0.40Q500) mosaic cases at the level of viable pregnancy of Table III could be regarded as CPM cases arisen by TZR of a trisomic conception, of which 5.5 are expected to show UPD. This means a UPD rate of 22 per 100 000 chorionic villus samples. This value is close to the maximal UPD rate of 28±35 per 100 000 chorionic villus samples reported for the chromosomes 2, 3, 7, 8, 9, 15, 16 and 22 together (Wolstenholme, 1996; EUCROMIC, 1999) .
As already stated above, randomness of the occurrence of TZR and MZR has been presumed in our model. Any trisomy has a chance of 1.7% of being corrected by TZR to trisomy/disomy mosaicism: 7048 of the abnormal zygotes undergoing the ®rst cell division show single trisomy [0.233 (fraction of single trisomy)Q30 250] out of which ultimately 122 mosaic cases are formed by TZR (1.7%). However, 10% of trisomy 16 conceptions have been estimated to undergo TZR (Wolstenholme, 1995) , probably indicating some kind of a governing mechanism. From a governing mechanism for TZR (and MZR), one would expect the effects in the earliest possible postzygotic cell division(s) with a suf®cient activity of the cell cycle control system. These are the ®rst division with the still strongest maternally derived control system and the fourth division with the embryonic control system becoming active. Furthermore, one would not expect a governing mechanism to be active in only 1 cell per embryo, except in the ®rst cell division.
However, restricting the correction by TZR to 1 cell, we will consider corrections in the different cell divisions by AL, the mechanism mostly involved in TZR, more closely. Correction in the ®rst cell division may result in N [16] or in the substantial mosaicism A [8] /N [8] at the 16-cell stage. Corrections in the second, third and fourth cell divisions result in the mosaicisms A [8, 12] / N [8, 4] , A [12, 14] /N [4, 2] and A [14, 15] /N [2, 1] at the 16-cell stage respectively (Los et al., 1998a) . Only the mosaicisms A [b12] / N [`4] can become a CPM I of non-mosaic trisomy 16 or a CPM III with non-mosaic trisomy 16 in trophoblast cells combined with a mosaic or non-mosaic trisomy 16 in the mesenchymal core of chorionic villi (EEM compartment). These types of CPM III and I are the regular appearance of trisomy 16 mosaicism at prenatal diagnosis (Wolstenholme, 1995 (Wolstenholme, , 1996 . Also UPD cases of other chromosomes show CPM III or I with high levels of mosaicism or non-mosaicism (Wolstenholme, 1996; Robinson et al., 1997) . This means that the surviving mosaic embryos would be those that had undergone TZR corrections as random events predominantly in the third and corrections under control of a governing mechanism in the fourth mitotic cell division. Under both circumstances, TZR corrections in these cell divisions deliver inverted`limited mosaicisms': the highest proportion of homogeneously (abnormal) cells and the lowest proportion of mitotically changed (normal) cells show apparently a higher rate of survival than the mosaic population as a whole. These mosaicisms probably provide a degree of homogeneity necessary for survival and successful implantation. The allocation of normal cells only to the compartment of the embryo/fetus proper at the 128-cell stage favours normal embryonic development after successful implantation.
The 16.4 CPM trisomy cases due to TZR in viable pregnancies at the end of the ®rst trimester of pregnancy among 122 TZRderived mosaic trisomy (A/N) embryos give a survival rate of 13. 4% (16.4/122) . This is higher than that of the population of mosaic embryos with A/N mosaicism at the virtual 8-cell stage of 3.1% [<500/(28 536 ± 12 616)] (see Tables III, IV and Figure 2 ). Almost all mosaic embryos at the end of the ®rst trimester of pregnancy show A/N mosaicism. Not included in the calculation of the survival rate are cases of generalized mosaicism of single trisomy/disomy with UPD of the disomic cell line. These cases are examples of a failed distribution of normal cells only to the compartment of the embryo/fetus proper (Christian et al., 1996; De Pater et al., 1997; Van den Berg et al., 1997; Los et al., 1998a) . The lack of data on the frequency of TZR cases among these generalized mosaicisms prevents a fair estimate of the number of such cases in our model. The occurrence of TZR and MZR as random events in our model is compatible with the encountered frequencies of CPM cases showing UPD in our opinion. However, a governing mechanism of moderate ef®ciency (estimated to be bene®cial to only 10% of the embryos with trisomy 16) cannot be excluded.
PGD can be performed for inherited diseases and chromosomal abnormalities with DNA or molecular cytogenetic techniques at different levels of in vitro embryonic development. Polar body biopsy for the investigation of the ®rst or ®rst and second polar body has been successfully performed on the yet unfertilized or fertilized oocyte (Verlinsky et al., 1996; Wells et al., 2002; Kuliev et al., 2003) . A limitation of PGD at the level of the polar body is the fact that the complement of the maternal genetic/chromosomal contribution to the embryo is investigated. Only the investigation of both the ®rst and second polar body includes the complement of abnormalities originating in maternal meiosis II and I (Kuliev et al., 2003) . Maternal meiotic errors, the major source of numerical chromosome disorders in spontaneous abortion and live birth, are the target of investigation. The problem of chromosomal mosaicism, the predominant abnormality in cleavage stage embryos and the main cause of developmental arrest before the blastocyst stage cannot be encountered.
The most used method of PGD and PGD-AS is the blastomere biopsy from cleavage stage embryos. The biopsy is preferentially performed around the 8-cell stage of development (Handyside, 1998; Vandervorst et al., 2000; ESHRE PGD Consortium Steering Committee, 2000) . However, biopsies at a later stage (morula or even blastocyst stage) have occasionally been carried out (Veiga et al., 1997) . A sample of 1 or 2 cells is taken from a mean 8-cell (range: 4±12-cell) embryo at day 3 of in vitro development when it consists out of`6 or b7 cells respectively Liebaers et al., 1998; Emiliani et al., 2000 Rubio et al., 2003) . Various authors prefer the 2-cell biopsy to the biopsy of just 1 blastomere for a more reliable diagnosis. The investigation of 2 cells carries a lower risk of laboratory failure and is believed to be more representative for the cytogenetic condition of the embryo in cases of chromosomal mosaicism (Harper and Delhanty, 1996; Van de Velde et al., 2000; Vandervorst et al., 2000; Wilton, 2002) .
The theoretical probabilities of the cytogenetic status of 1-cell biopsies (1 normal or 1 abnormal cell) and 2-cell biopsies (2 normal, 1 normal + 1 abnormal or 2 abnormal cells) from 8-cell embryos with all possible levels of mosaicism are presented in Figures 3 and 4 . Furthermore, the cytogenetic conditions of the remaining 7-or 6-cell post-biopsy embryos are given. The multiplication of the numbers of normal, abnormal and mosaic embryos at the 8-cell stage (Table III and Figure 2 ) by the probabilities of biopsy and post-biopsy embryo compositions (Figures 3 and 4) delivers the numbers of normal, abnormal and mosaic post-biopsy embryos at each biopsy result (Table V) . Normal results are encountered in 47.9% of the 1-cell biopsies (39 539/82 500) and in 40.1% of the 2-cell biopsies (33 063/ 82 500). However, the predictive values of these normal results are rather limited, since only 54.0% (21 361/39 539) and 64.6% (21 361/33 063) of the normal biopsies represent a normal postbiopsy embryo in case of a 1-cell or a 2-cell biopsy respectively.
A minority of 43.9% of the mosaic (A/N) post-biopsy embryos [11 830/(11 634 + 11 830 + 3494) ] is correctly represented by a 2-cell (A/N) biopsy whereas a 1-cell biopsy cannot represent mosaicism. We have seen above that the majority of mosaic embryos displays limited mosaicism of which a signi®cant part is presumed to return to normality or homogeneous abnormality at least when the embryo is not subjected to a biopsy procedure. An abnormal or mosaic biopsy reduces or even eliminates the limited mosaicism from the embryo but decreases its chance for transfer. In contrast, a normal biopsy aggravates the mosaicism in the embryo but increases its chance for transfer. This risk of aggravation of mosaicism is greater in the case of a 2-cell than a 1-cell biopsy because more normal blastomeres are removed in the former situation. This problem concerns as many as 9080 (3263 + 5817) embryos of which a 2-cell biopsy was taken and 11 950 (3806 + 8144) embryos in case of a 1-cell biopsy (see Table V ). Mosaic (A/N) 2-cell biopsies change the pre-biopsy embryos with the limited mosaicisms A [1] /N [7] and A [2] /N [6] into the post-biopsy embryos N [6] (1087 cases) and A [1] /N [5] (4654 cases) ( Table V) . A proportion of 83% of these cases would show mosaicism of 1 or 2 lethal cells (see Mechanisms) and turn to normality. Theoretically, 4950 of the 5741 (1087 + 0.83Q4654) embryos would be transferable to the prospective mother of which 4765 [(0.83Q(1087 + 4654) ] would have been recognized with the biopsy (96.3%). So, 48.5% of the mosaic biopsies with a lethal cell (4765/0.83Q11 830) could be expected to represent a viable embryo. In the absence of embryos with normal biopsy results, one might decide to transfer embryos with biopsies displaying mosaicism of a lethal cell. The missing of mosaic cases but also the rejection of potentially good embryos have been considered as serious problems for PGD-AS .
The 1-cell biopsy protocol allows for the transfer of 47.9% of the embryos showing normal biopsy results with a predictive value of 54.0%: for the 2-cell biopsy protocol these values are 40.1 and 64.6% respectively. In a PGD population with a mix of 1-and 2-cell biopsy procedures, a rate of transferable embryos between 40.1 and 47.9% can be expected. In the population of PGD for social sexing with a majority of fertile couples but an increased average maternal age of 36 years, a percentage of 41% has been encountered (ESHRE PGD Consortium Steering Committee, 2002) . The implementation of the considerations on mosaic biopsies would improve the 2-cell biopsy protocol, in which case the transfer of 33 063 embryos with normal biopsies plus the 9819 (0.83Q11 830) with mosaicism of a lethal cell in the biopsy could be considered. These 42 882 out of 82 500 biopsies (52.0%) would show a predictive value of 60.9% [(21 361 + 4765)/42 882] (see Table V ). On the one hand, the 2-cell biopsy shows a higher transfer rate with a slightly higher predictive value than the 1-cell biopsy. On the other hand, the 2-cell biopsy carries a higher risk of aggravation of mosaicism and would theoretically display more adverse effects of the biopsy compared to the 1-cell biopsy. However, embryo development seems not to be compromised to a greater extent by the removal of 2 blastomeres instead of 1 at the 8-cell stage (Hardy et al., 1990; Liu et al., 1993; Van de Velde et al., 2000) . The removal of a quarter of the blastomeres at the 4-or 5-cell stage embryo might retard further cleavage (Tarin et al., 1992) .
From the data in Table V , the theoretical false-negative and false-positive rates can easily be calculated: 22.0% [(18 161 + 17)/ 82 500] and 12.6% [(544 + 9814)/82 500] in case of a 1-cell biopsy; 14.2% [(11 634 + 68 + 35)/82 500)] and 6.0% [(1087 + 388 + 3494)/82 500)] in case of a 2-cell biopsy. In the literature, the sum of false-negative and false-positive rates in PGD-AS has been designated type 1 error . In PGD studies using FISH for six or nine chromosomes (X, Y, 13, 16, 18, 21 , in some cases additionally 14, 15 and 22), Munne Â et al. (1998) established false-negative and false-positive rates of 4 and 14% respectively (type 1 error rate of 18%). For the same chromosomes (X, Y, 13, 16, 18, 21 , in some cases additionally 15 and 22), Silber et al. (2003) established rates of 11.8 and 7.8% (type 1 error rate of 19.6%). A potential bias in the calculations of these error rates is the fact that embryos with normal biopsy results are likely to be transferred to the prospective mother and withdrawn from further con®rmational investigations. This leads to an underestimate of the false-negative rate and hence of the type 1 error rate in PGD-AS studies. Notwithstanding this limitation, the encountered values of false-negative and false-positive rates associated with the detection of the numerical abnormalities of a set of six to nine chromosomes ®t well into our theoretical values. Different abnormal ®ndings in biopsies and remaining embryos in Table V . Theoretical numbers of normal and abnormal 1-cell biopsies and of normal, mosaic and abnormal 2-cell biopsies from 8-cell embryos in relation to the cytogenetic condition of the 7/6-cell post-biopsy embryos con®rmational studies are designated type 2 errors . In our model, these errors are included in the correct diagnoses (A, A/N and A/A), since no diagnosis of mosaicism can be made at all in case of a 1-cell biopsy and not of multiple mosaicism in case of a 2-cell biopsy. The majority of mosaic embryos (62%) has been shown to contain b3 different cells/cell lines. From a theoretical point of view, the 8-cell stage seems not the most suitable level for PGD(-AS) as shown in the Tables III, IV and Figure 1 ; the lowest rate of normal embryos and the highest rate of abnormal and mosaic embryos are present at this stage. The post-biopsy 6/7-cell embryo turned out to have a different prospect of development than the pre-biopsy 8-cell embryo in the case of limited mosaicism. This leads to the paradoxical effect of an inverse relation between the developmental prospects of these embryos and their chances for transfer. We hope to have contributed to the understanding of the fate of normal, abnormal and mosaic embryos with our theoretical model.
